Clinical Trial Update: Post ERCP Pancreatitis Prevention in Average Risk Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating prevention of post-ERCP pancreatitis in average-risk patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Snippet

Sponsor: University Hospital Rijeka | Conditions: Pancreatitis | Phase 4 | Status: COMPLETED